PharmacoEconomics & Outcomes News

, Volume 832, Issue 1, pp 5–5 | Cite as

Assessing cost effectiveness of second-line HIV regimens in Africa

Clinical study


  1. Boyer S, et al. Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa. PharmacoEconomics-Open : 4 Jul 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations